Edwards Lifesciences (EW)
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
$99.37+4.39%
Close 2026-11-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · EW
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 6,674.7 | 6,067.6 | 5,439.5 | 5,010.0 | 4,464.0 | 5,232.5 | 4,386.3 | 4,348.0 | 2,963.7 | 2,963.7 | 2,963.7 | 2,493.7 | 1,899.6 | 1,899.6 | 1,899.6 | 1,678.6 | 1,237.7 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 2,963.7 | 2,963.7 | 2,493.7 | 1,899.6 | 1,899.6 | 1,899.6 | 1,678.6 | 1,237.7 |
| Cost of Revenues | 1,467.2 | 1,334.2 | 1,117.5 | 978.4 | 723.7 | 1,248.9 | 1,080.6 | 1,114.4 | 797.4 | 797.4 | 797.4 | 617.2 | 491.0 | 494.6 | 494.6 | 489.8 | 419.6 |
| Gross Profit | 5,207.5 | 4,733.4 | 4,322.0 | 4,031.6 | 3,740.3 | 3,983.6 | 3,305.7 | 3,233.6 | 2,166.3 | 2,166.3 | 2,166.3 | 1,876.5 | 1,408.6 | 1,405.0 | 1,405.0 | 1,188.8 | 818.1 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 2,247.2 | 2,085.2 | 1,789.2 | 1,582.5 | 1,357.6 | 1,493.7 | 1,228.4 | 1,242.2 | 904.7 | 904.7 | 904.7 | 850.7 | 697.4 | 705.3 | 705.3 | 642.4 | 480.6 |
| R&D Expenses | 1,091.3 | 1,079.2 | 1,053.0 | 962.9 | 843.6 | 903.1 | 760.7 | 752.7 | 442.2 | 442.2 | 443.3 | 383.1 | 291.3 | 291.3 | 291.3 | 246.3 | 139.2 |
| Other Operating Expenses, Total | 52.8 | 67.2 | 0.3 | 0.0 | 0.0 | — | — | 0.0 | 0.0 | — | — | — | — | — | — | — | — |
| Operating Income | 1,441.0 | 1,264.2 | 1,378.7 | 1,308.9 | 1,498.4 | 1,690.3 | 897.6 | 1,146.8 | 751.2 | — | — | — | — | — | — | — | — |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 20.4 | 19.8 | 17.6 | 19.2 | 18.4 | 15.8 | 20.7 | 19.2 | 19.2 | 19.2 | 17.2 | 4.4 | 4.4 | 4.4 | 3.1 | 7.2 |
| Interest & Investment Income | 156.3 | 168.8 | 120.3 | 67.2 | 35.5 | 17.4 | 23.4 | 32.2 | 10.8 | 10.8 | 10.8 | 7.9 | 4.8 | 4.8 | 4.8 | 3.4 | 6.1 |
| Net Interest Expenses | — | — | — | (49.6) | (16.3) | 1.0 | (7.6) | (11.5) | 8.4 | 8.4 | 8.4 | 9.3 | (0.4) | (0.4) | (0.4) | (0.3) | 1.1 |
| Other Non-Operating Income / Expenses | (8.6) | 8.7 | 169.4 | 63.5 | 21.1 | — | — | — | — | — | — | — | — | — | — | 4.8 | (7.7) |
| Asset Writedown | — | 186.9 | — | 0.0 | 55.1 | 4.0 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 1,432.4 | 1,272.9 | 1,548.1 | 1,372.4 | 1,519.5 | 1,702.0 | 916.7 | 1,166.5 | 737.9 | 737.9 | 737.9 | 622.4 | 388.2 | 391.1 | 391.1 | 283.6 | 164.4 |
| Income Tax Expense | 444.7 | 216.9 | 152.1 | 152.4 | 195.5 | 198.9 | 93.3 | 119.6 | 168.4 | 168.4 | 168.4 | 127.5 | 96.7 | 97.9 | 97.9 | 46.9 | 35.5 |
| Earnings from Continuing Operations | 987.7 | 1,056.0 | 1,396.0 | 1,220.0 | 1,324.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | |||||||||||||||||
| Minority Interest | — | (4.1) | (4.9) | (3.0) | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | 1,021.3 | 1,073.5 | 4,174.6 | 1,402.4 | 1,521.9 | 1,503.1 | 823.4 | — | — | — | — | — | — | — | — | — | — |
| Per Share | |||||||||||||||||
| Basic EPS | 1.77 | 1.84 | 6.98 | 2.31 | 2.46 | 2.41 | 1.32 | 5.03 | 2.67 | 2.67 | 2.67 | 2.30 | 2.54 | 2.55 | 2.55 | 2.07 | 1.15 |
| Diluted EPS | 1.77 | 1.83 | 6.97 | 2.30 | 2.44 | 2.38 | 1.30 | 4.93 | 2.61 | 2.61 | 2.61 | 2.25 | 2.46 | 2.48 | 2.48 | 1.98 | 1.10 |
| Revenue per Share | 11.56 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 576.3 | 584.8 | 597.7 | 606.7 | 619.0 | 623.3 | 622.6 | 208.3 | 213.0 | 213.0 | 213.0 | 215.5 | 114.9 | 114.9 | 114.9 | 114.6 | 111.7 |
| Diluted Weighted Avg Shares | 577.6 | 585.8 | 599.3 | 609.4 | 624.2 | 631.2 | 631.9 | 212.2 | 217.8 | 217.8 | 217.8 | 220.3 | 118.3 | 118.3 | 118.3 | 119.4 | 119.2 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 1,420.8 | 1,533.9 | 1,453.8 | 1,638.0 | 1,825.1 | 1,004.8 | 1,236.1 | 822.4 | — | — | — | — | — | — | — | — |
| EBIT | 1,441.0 | 1,264.2 | 1,378.7 | 1,308.9 | 1,498.4 | 1,690.3 | 897.6 | 1,146.8 | 751.2 | — | — | — | — | — | — | — | — |
| Effective Tax Rate | 31.0% | — | — | 11.1% | 12.9% | 11.7% | 10.2% | 10.3% | 22.8% | 22.8% | 22.8% | 20.5% | 24.9% | 25.0% | 25.0% | 16.5% | 21.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.